Overview

Dacarbazine and Carmustine in Metastatic Melanoma

Status:
Terminated

Trial end date:
2014-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether dacarbazine and carmustine at the doses and schedule used in this study will help to increase tumor shrinkage.

Phase:

Phase 2

Details

Lead Sponsor:

Western Regional Medical Center

Treatments:

Carmustine
Dacarbazine